Peptide HC, with zinc attached

Zinc and thymulin

The hormone’s apparent simplicity appealed to me. In the 1994 review of zinc and thymulin, the metal does an extraordinary amount of the work. Thymulin is a chain of nine amino acids made by thymic epithelial cells; its biological activity requires a bound zinc ion. Zinc deficiency lowered serum thymulin activity in animals and humans, and zinc supplementation corrected it. The chain and its active form have to be considered together.

A low activity measurement raises a question about the peptide's surroundings as well as the peptide itself. The same review describes a particular zinc-bound shape, detected by nuclear magnetic resonance. There is chemistry inside the health claim, and the chemistry has a condition attached.

The thymulin essay begins there, then follows the hormone into T-cell maturation, pituitary signals and a striking mouse lung experiment.

Intestinal KPV experiments

KPV brings another kind of dependency. This three-amino-acid fragment of alpha-MSH has been studied in inflamed intestinal tissue, where a transporter called PepT1 carries it into cells. In cultured human intestinal cells and mouse colitis experiments, uptake accompanied reduced inflammatory signaling. The human cells were growing in culture; the treated animals were mice.

The receptor experiment is my favourite complication: colitis work that included mice lacking MC1R, a melanocortin receptor associated with KPV's parent hormone. KPV's anti-inflammatory activity persisted. Removing MC1R is a satisfyingly concrete test: take away a suspected requirement and see whether the effect survives. It survived in that model.

The KPV page follows the sequence, mechanism of action, formulations and missing human studies. The comparison puts its gut experiments beside thymulin's very different settings.

Health and experimental conditions

The name Peptide HC suggests health care to me. In these papers, care starts with attention to zinc, a cell type, a formulation or the timing of an experiment. I distrust immunity claims that leave out the zinc, cell type and formulation. Thymulin's physiology and KPV's cellular uptake offer plenty to be curious about before anyone reaches a clinical claim.

Neither KPV nor thymulin is an approved medicine. KPV has no published human clinical trials in this literature; thymulin's human evidence is sparse, with biochemical work and early investigations that leave therapeutic questions unresolved. The questions page deals with those gaps and safety. Medical decisions need an individual clinical assessment, which these essays cannot provide.

HC peptide and protein HC

For a search such as “hc peptide” or “protein HC”, a name alone leaves a lot open. Peptide HC is the name of this site; the molecules discussed here are KPV and thymulin. Their sequences, origins and experimental uses are set out on their respective pages. Start with KPV for the alpha-MSH fragment, or thymulin for the zinc-dependent thymic hormone.